Johnson & Johnson (JNJ) Other Non Operating Income (2009 - 2026)

Johnson & Johnson has disclosed Other Non Operating Income across 18 years of filings, most recently posting -$294.0 million for Q1 2026.

• Other Non Operating Income for Q1 2026 came in at -$294.0 million, down 104.02% year-over-year; the trailing twelve-month figure through Mar 2026 was -$406.0 million (down 108.07% YoY), and the FY2025 annual result was $7.2 billion, up 253.58% from the prior year.
• Other Non Operating Income came in at -$294.0 million for Q1 2026 at Johnson & Johnson, up from -$483.0 million in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $7.3 billion in Q1 2025 to a low of -$6.9 billion in Q2 2023.
• The 5-year median for Other Non Operating Income is -$273.0 million (2022), against an average of -$302.4 million.
• Across the five-year window, Other Non Operating Income sank 6903.92% in 2023 and surged 404.53% in 2025, its largest moves.
• Johnson & Johnson's Other Non Operating Income stood at -$226.0 million in 2022, then surged by 286.28% to $421.0 million in 2023, then plunged by 61.76% to $161.0 million in 2024, then plunged by 400.0% to -$483.0 million in 2025, then surged by 39.13% to -$294.0 million in 2026.
• The last three Other Non Operating Income figures came in at -$294.0 million (Q1 2026), -$483.0 million (Q4 2025), and $478.0 million (Q3 2025), per Business Quant data.